Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta‐Analysis

Movement Disorders - Tập 37 Số 12 - Trang 2327-2335 - 2022
Alex Medina1, Yasamin Mahjoub1, Larry Shaver2, Tamara Pringsheim1,3,4
1Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
2Adult Chronic Diseases and Conditions Division Public Health Agency of Canada Nepean Ontario Canada
3Department of Psychiatry, Pediatrics, Community Health Sciences University of Calgary Calgary Alberta Canada
4Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

Tóm tắt

ABSTRACTThe incidence and prevalence of Huntington's disease (HD) based on a systematic review and meta‐analysis of 20 studies published from 1985 to 2010 was estimated at 0.38 per 100,000 person‐years (95% confidence interval [CI], 0.16–0.94) and 2.71 per 100,000 persons (95% CI, 1.55–4.72), respectively. Since 2010, there have been many new epidemiological studies of HD. We sought to update the global estimates of HD incidence and prevalence using data published up to February 2022 and perform additional analyses based on study continent. Medline and Embase were searched for epidemiological studies of HD published between 2010 and 2022. Risk of bias was assessed using a quality assessment tool. Estimated pooled prevalence or incidence was calculated using a random‐effects meta‐analysis. A total of 33 studies published between 2010 and 2022 were included. Pooled incidence was 0.48 cases per 100,000 person‐years (95% CI, 0.33–0.63). Subgroup analysis by continent demonstrated a significantly higher incidence of HD in Europe and North America than in Asia. Pooled prevalence was 4.88 per 100,000 (95% CI, 3.38–7.06). Subanalyses by continent demonstrated that the prevalence of HD was significantly higher in Europe and North America than in Africa. The minor increase in prevalence (more so than incidence) demonstrated in this updated review could relate to the enhanced availability of molecular testing, earlier diagnosis, increased life expectancy, and de novo mutations. Limitations include variable case ascertainment methods and lacking case validation data. © 2022 Her Majesty the Queen in Right of Canada. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. Reproduced with the permission of the Minister of Public Health Agency of Canada.

Từ khóa


Tài liệu tham khảo

Caron NS, 1993, GeneReviews

10.1038/ng0893-387

10.1002/mdc3.12808

10.1002/mds.25075

10.1136/jnnp-2012-304636

10.1159/000444020

10.1002/mds.25717

10.1111/cge.12574

10.1136/bmjopen-2015-009070

10.1111/cge.13168

10.1007/s00415-021-10505-w

10.1080/13696998.2022.2033493

10.1002/ajmg.b.32618

Syst Rev Preferred reporting items for systematic review and meta‐analysis protocols (PRISMA‐P) 2015 statement

10.1159/000321712

10.1186/1471-2458-14-653

10.3233/JHD-150158

10.2217/nmt-2016-0008

10.1159/000443738

Riccò M, 2020, Prevalence of Huntington disease in Italy: a systematic review and meta‐analysis, Acta Biomed, 91, 119

Dastgiri S, 2012, Epidemiology of neuro‐genetic disorders in northwestern Iran, Neurosciences, 17, 171

Douglas I, 2013, Juvenile Huntington's disease: a population‐based study using the general practice research database, BMJ Open, 3, 10.1136/bmjopen-2012-002085

10.1159/000331912

10.1159/000337680

10.3233/JHD-210500

10.1159/000479697

10.1093/pubmed/fdx176

10.1007/s10072-021-05217-y

10.1186/s12883-019-1556-3

10.1111/j.1399-0004.2010.01603.x

10.14802/jmd.14038

10.1186/s12881-020-01174-z

10.1186/s13023-021-01699-3

10.1007/s10072-021-05085-6

10.1002/mds.27653

10.1212/WNL.0000000000002486

10.1159/000434630

10.1590/1678-4685-gmb-2018-0032

10.1002/mdc3.12474

10.1111/cge.12984

10.1016/j.parkreldis.2014.10.025

10.1016/j.parkreldis.2020.09.011

10.1111/j.1399-0004.2010.01538.x

10.1136/jnnp-2020-323241

10.1111/ane.12762

10.1038/s41436-020-0895-1

10.1038/ejhg.2013.2

10.1159/000184748

10.1159/000516767